QIAGEN NV (QGEN) Covered Calls

QIAGEN NV covered calls QIAGEN NV is a provider of innovative technologies and products for preanalytical sample preparation and linked molecular assay solutions. The Company also supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics.

You can sell covered calls on QIAGEN NV to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for QGEN (prices last updated Fri 4:16 PM ET):

QIAGEN NV (QGEN) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
36.66 +0.45 36.66 37.75 1.0M 148 8.2B
Covered Calls For QIAGEN NV (QGEN)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jul 20 35 0.00 37.75 -7.3% -91.9%
Aug 17 35 0.05 37.70 -7.2% -46.1%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

QIAGEN NV is engaged in the provision of sample and assay technologies. Its products include instruments and consumables. The company's Sample technologies are used to isolate DNA (deoxyribonucleic acid), RNA (ribonucleic acid) and proteins from any biological sample, such as blood or tissue as well as plants and other samples that contain biological materials. Its Assay technologies are used to amplify, enrich and provide results for analysis, such as the DNA of a virus or a mutation of a gene contained in a cancer cell, and these are supported by a portfolio of industry-leading bioinformatics solutions. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, Netherlands.